Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Acquired_by_AmerisourceBergen_in_2016
|
| gptkbp:awards |
recognized for innovation in pharmaceuticals
|
| gptkbp:businessModel |
focuses on business growth strategies
focused on generics and injectables |
| gptkbp:clinicalTrials |
conducts clinical research studies
conducts clinical trials for new products follows clinical guidelines for product development |
| gptkbp:communityEngagement |
involvement in local communities
|
| gptkbp:communityOutreach |
international distribution capabilities
|
| gptkbp:communityPartnerships |
establishes supply partnerships with manufacturers
|
| gptkbp:competitors |
conducts market analysis for strategic planning
|
| gptkbp:corporateSocialResponsibility |
engages in corporate social responsibility initiatives
|
| gptkbp:customerBase |
hospitals and clinics
|
| gptkbp:customerFeedback |
values customer feedback for improvement
|
| gptkbp:customerSupport |
dedicated customer support team
|
| gptkbp:distribution |
wholesalers and distributors
|
| gptkbp:employees |
approximately 300
offers competitive employee benefits |
| gptkbp:financialPerformance |
publicly traded company
|
| gptkbp:financials |
publishes annual financial reports
|
| gptkbp:focus |
generic injectable pharmaceuticals
|
| gptkbp:founded |
2006
|
| gptkbp:founder |
Jeffrey_M._Yordon
|
| gptkbp:headquarters |
gptkb:Schaumburg,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sagent Pharmaceuticals
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:innovation |
dedicated to innovation in drug development
|
| gptkbp:investmentFocus |
invests in new technologies
maintains investor relations department |
| gptkbp:isFacilitatedBy |
stringent quality standards
|
| gptkbp:leadership |
experienced executive team
|
| gptkbp:market |
gptkb:United_States
plans for market expansion. regular product launches monitors market trends in pharmaceuticals |
| gptkbp:marketSegment |
focused marketing strategies
|
| gptkbp:mission |
improve patient outcomes
|
| gptkbp:parentCompany |
AmerisourceBergen_Corporation
|
| gptkbp:partnerships |
collaborations with healthcare providers
strategic partnerships with other companies explores partnership opportunities with other firms |
| gptkbp:productLine |
over 100 injectable products
|
| gptkbp:productQuality |
ensures high product quality standards
|
| gptkbp:products |
injectable drugs
focus on product safety and efficacy ongoing product development initiatives |
| gptkbp:regulatoryCompliance |
FDA_approved_products
compliance_with_FDA_regulations |
| gptkbp:research |
allocates funding for research projects
|
| gptkbp:research_areas |
various therapeutic areas including anesthesia
|
| gptkbp:researchAndDevelopment |
focus on oncology and critical care
|
| gptkbp:stockSymbol |
SGNT
|
| gptkbp:supplyChain |
global supply chain management
efficient supply chain management practices |
| gptkbp:sustainability |
commitment to sustainable practices
|
| gptkbp:teamAchievements |
diverse product portfolio
|
| gptkbp:training |
provides employee training programs
|
| gptkbp:website |
www.sagentpharma.com
|